Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 15 May 24 424B3 Prospectus supplement
- 27 Jun 22 EFFECT Notice of effectiveness
- 22 Jun 22 POS AM Prospectus update (post-effective amendment)
- 29 Mar 22 EFFECT Notice of effectiveness
- 28 Mar 22 POS AM Prospectus update (post-effective amendment)
- 29 Mar 21 EFFECT Notice of effectiveness
- 26 Mar 21 POS AM Prospectus update (post-effective amendment)
- 28 Aug 20 424B4 Prospectus supplement with pricing info
- 28 Aug 20 EFFECT Notice of effectiveness
- 27 Aug 20 S-1/A IPO registration (amended)
- 26 Aug 20 S-1/A IPO registration (amended)
- 20 Aug 20 S-1/A IPO registration (amended)
-
2 Jul 20 S-1 IPO registration
PBLA similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the reference to our firm under the caption “Experts” in this Registration Statement on Form S-1 and related prospectus of Sun BioPharma, Inc. and to the inclusion therein of our report, dated March 24, 2020, with respect to the consolidated financial statements of Sun BioPharma, Inc. appearing in its Form 10-K filed March 24, 2020 with the Securities and Exchange Commission.
/s/ Cherry Bekaert LLP
Tampa, Florida
July 2, 2020